Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRABD antisense RNA 1 (TRABD-AS1)
- Target
- TRABD-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Natural antisense transcript (NAT)
01
Overview
TRABD antisense RNA 1 (TRABD-AS1) is a long noncoding natural antisense transcript found in humans and other mammals. NATs like TRABD-AS1 are typically transcribed from the opposite DNA strand at the locus of a protein-coding gene—in this case, the TRABD gene—potentially regulating gene expression through RNA-RNA interactions, transcriptional interference, or epigenetic effects. The general function of NATs includes modulating their sense genes by forming duplexes that may affect mRNA stability, translation, or chromatin state, although the specific biological roles, disease relevance, and mechanisms for TRABD-AS1 remain undetermined in published literature as of now.
- Other names
- TRABD-AS1
02
Mechanism of action
Not applicable; there are no drugs targeting TRABD-AS1 at present
03
Biological functions
Regulation of gene expression (cis and/or trans mechanisms)Potential epigenetic regulation (as observed for other antisense RNAs)
04
Disease associations
None clearly established; no direct association with cancer, inflammation, cardiovascular, or other diseases is currently reported for TRABD-AS1
05
Safety considerations
None known; no therapeutic development or safety literature is available for TRABD-AS1
06
Interacting drugs
None reported; no drugs are currently known or documented to directly interact with TRABD-AS1
07
Biomarkers
None reported; TRABD-AS1 has not been described as a biomarker for patient selection or efficacy monitoring in any disease context
Beyond the preview
Go deeper on TRABD antisense RNA 1 (TRABD-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRABD antisense RNA 1 (TRABD-AS1).